Stockreport

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Aethlon Medical, Inc.  (AEMD) 
NASDAQ:AMEX Investor Relations: ir.aethlonmedical.com
PDF Aethlon's Trial is a Safety, Feasibility, and Dose Finding Study of the Hemopurifier® in Patients with Solid Tumors Not Responding to Anti-PD-1 AntibodiesSAN DIEGO, Sept [Read more]